DOI QR코드

DOI QR Code

A Case Report of Complex Korean Medicine Treatment Including Modified Gamiguibi-tang in a Paraneoplastic Cerebellar Degeneration Patient with Dysarthria and Weakness of Distal Extremity

구음장애와 사지원위부 무력감을 호소하는 신생물딸림소뇌변성 환자에 대한 가미귀비탕가감방을 포함한 한의복합치료 1례

  • Ji-hyeon Kang (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Haany University Korean Medicine Hospital) ;
  • Seo-hyun Kim (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Haany University Korean Medicine Hospital) ;
  • Chae-eun Kim (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Haany University Korean Medicine Hospital) ;
  • Hee-ju Won (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Haany University Korean Medicine Hospital) ;
  • Kyungmin Baek (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Haany University Korean Medicine Hospital)
  • 강지현 (대구한의대한방병원 심계내과학교실) ;
  • 김서현 (대구한의대한방병원 심계내과학교실) ;
  • 김채은 (대구한의대한방병원 심계내과학교실) ;
  • 원희주 (대구한의대한방병원 심계내과학교실) ;
  • 백경민 (대구한의대한방병원 심계내과학교실)
  • Received : 2024.05.25
  • Accepted : 2024.07.02
  • Published : 2024.06.30

Abstract

Objectives: This study investigated the treatment response to Korean medicine of a paraneoplastic cerebellar degeneration (PCD) patient with dysarthria and weakness of distal extremity. Case presentation: A 53-year-old female diagnosed with PCD complained of dysarthria and weakness of distal extremity. During 32-day hospitalization, she was treated with Korean medicine, namely, herbal medicine (modified Gamiguibi-tang), acupuncture (15 minutes twice a day at CV23, HT7, LI4, LR3, ST36, SP6, GB20, TE17, PC6, GV20, Ex-HN1, GV24 etc.), moxibustion, and cupping, combined with Western medicine (prednisolone, azathioprine) and physical therapy. Post-treatment, the patient global assessment (PGA) score of dysarthria fell from 100 to 60; grasp power rose from 15 kg to 19 kg and 13 kg to 17 kg in the right and left hands, respectively; and the 5-level EQ-5D version (EQ-5D-5L), EQ visual analogue scale (EQ-VAS), and Beck depression inventory (BDI-II) scores changed from 10 to 8, 0 to 80, and 34 to 7 respectively. Follow-up visits continued for about a month after discharge, improvement in symptoms maintained, and there were no significant side effects. Conclusions: Given the lack of standard treatment for PCD, Korean medicine can be tried clinically for the treatment of PCD patients with dysarthria and weakness of distal extremity. However, further studies with control groups are needed.

Keywords

References

  1. Song SH, Park CH, Park JW. Anti-Yo-associated paraneoplastic cerebellar degeneration in a patient with chemotherapy-responsive ovarian cancer: A case report with a review of literatures. Obstetrics & Gynecology Sci 2008;51(12):1528-3. 
  2. Korean Neurological Association. Neurology. 3rd rev Seoul: Panmun; 2017, p. 706-7. 
  3. Loehrer PA, Zieger L, Simon OJ. Update on Paraneoplastic Cerebellar Degeneration. Brain Sci 2021;11(11):1414. 
  4. Uyar B. The analysis of immunosuppressant therapy adherence, depression, anxiety, and stress in kidney transplant recipients in the post-transplantation period. Transpl Immunol 2022;75:101686. 
  5. Ramasamy V. Acupuncture for the Treatment of Paraneoplastic Night Sweats. J Acupunct Meridian Stud 2018 Aug;11(4):159-61. 
  6. Lee WJ, Kim YJ, Roh SS. A Literature study on the language disturbance. J Orient Med Surg Ophthalmol Otolaryngol 1997;10(1):159-84. 
  7. Kim SH, Ahn JH, Ock MS, Shin SJ, Park JY, Luo N, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res 2016;25(7):1845-52. 
  8. Devlin N, Roudijk B, Ludwig K. Value Sets for EQ-5D-5L:A Compendium, Comparative Review &User Guide Cham: Springer; 2022, p. 1-12. 
  9. Sung HM, Kim JB, Park YN, Bai DS, Lee SH, Ahn HN. A Study on the Reliability and the Validity of Korean Version of the Beck Depression Inventory-II(BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14(2):201-12. 
  10. The Korean Society of Oriental Neuropsychiatry. Clinical Practice Guideline of Korean Medicine :Anxiety Disorder. Seoul: Koonja; 2021, p. 74. 
  11. Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol 2013;15(2):185-200. 
  12. Kim JM, Cho KH, Park MH, Lee SH. Paraneoplastic Cerebellar Degeneration with Anti-Yo Antibody Manifested by Central Nystagmus and Abnormal Head Impulse Test. Clin Neuroophthalmol 2017;7(2):41-5. 
  13. Yu SY, Nho JH. Influence of Sleep Disturbance and Depression on Quality of Life in Ovarian Cancer Patients during Chemotherapy. Asian Oncol Nurs 2015;15(4):203-10. 
  14. Association of Korean Medicine Professors for Cardiovascular and Neurological Medicine. Cardiovascular and Neurological Medicine in Korean Medicine I. reviseded Seoul: Woori Medicine publication; 2016, p. 301-6. 
  15. The National College of Korean Medicine Spleen System International Medicine classroom. Spleen system medicine in Korean medicine. Seoul: Koonja; 2019, p. 63-8. 
  16. Kim DC, Noh SH, Lee SI, Lee YJ, Joo YS. Bangjehak. Seoul: YoungRimsa; 2007, p. 290-1. 
  17. Lee MH, Son BW, Kim KM, Kim YK. A Case Report on the Effects of Gamiguibi-tang Combined with Sweet Bee Venom to Improve Raynaud's Disease. J Int Korean Med 2017;38(5):698-708. 
  18. No DJ, Jung IC. Study on Effect to Serotonin Metabolism of Gamiguibi-tang on P815 Cell. J Orient Neuropsychiatry 2010;21(1):1-11. 
  19. Kim HC, Chung DK. A study of the comparative effect of Kuibitang, Kamiondarmtang, and Kuibiondarmtang on serum levels in rats under the immobilization stress. J Orient Neuropsychiatry 1993;4(1):99-119. 
  20. Lim JW, Kim JW, Chung SY, Cho SH, Oh MS, Hwang WW. The Antioxidative and Neuroprotective Effect of Guibi-tang(Guipitang) and Guibi-tang gamibang(Guipitang jiaweijang) on PC12 cells. J Orient Neuropsychiatry 2009;20(1):1-19. 
  21. Park SB, Yoon JH, Kim EH, Yoon SW. A Case Report of Chemotherapy-Induced Peripheral Neuropathy Treated with Modified Guibi-tang. J Int Korean Med 2022;43(3):451-9.